Ho, Sharon http://orcid.org/0000-0002-1975-828X
Ly, Angelica
Ohno-Matsui, Kyoko http://orcid.org/0000-0002-8375-6879
Kalloniatis, Michael
Doig, Gordon S. http://orcid.org/0000-0003-2141-7000
Funding for this research was provided by:
SH is supported by a Centre for Eye Health/Guide Dogs NSW/ACT Higher Degree Research Postgraduate Award. No other funding was received to support this project.
Article History
Received: 11 April 2022
Revised: 26 June 2022
Accepted: 25 August 2022
First Online: 2 December 2022
Competing interests
: SH: Financial Support (to individual)—Centre for Eye Health/Guide Dogs NSW/ACT Higher Degree Research Postgraduate Award. AL: Financial Support (to institution)—Novartis Australia and the Australian Human Rights Institute. KOM: Financial Support (to institution)—the Japanese Society for the Promotion of Science; Consulting fees—Santen Pharmaceuticals and Coopervision; Speaker’s Honoraria—Santen Pharmaceuticals, Novartis and Canon; and patents with Topcon Healthcare. MK: Financial Support (to institution)—the Australian National Health and Medical Research Council, Novartis Australia and Guide Dogs NSW/ACT. GSD: Financial Support (to institution)—the Australian National Health and Medical Research Council, the Australian Human Rights Institute, Fresenius Kabi Deutschland GmbH, and Baxter Healthcare Australia; Speakers’ Honoraria—Fresenius Kabi Deutschland GmbH, Baxter Healthcare Australia, Nestlé Healthcare, and Nutricia Pharmaceutical (Wuxi) outside the submitted work. No other disclosures were reported.